Stocks in Focus: Oncolytics Biotech, ANADIGICS, Mitek Systems, Gevo

Lakeway, TX -- (SBWIRE) -- 02/21/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) stock dropped 16.49% to $3.90 after the company yesterday announced that the pricing of an underwritten public offering of 8.0 million common shares, at a public offering price of $4.00 per common share. The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Oncolytics, will be $32.0 million. The offering is expected to close on or about February 25, 2013, subject to customary closing conditions.

Is ONCY a Buy After The Latest Announcement? Find out Here

ANADIGICS, Inc. (NASDAQ:ANAD) shares fell 14.29% and closed at $2.40. The company, on Feb. 19, reported fourth quarter 2012 net sales of $30.5 million, an increase of 6.4% sequentially and a decrease of 16.5% from the fourth quarter of 2011. Revenue for the full year 2012 of $112.6 million decreased 26.3% on an annual basis.

Additionally, ANAD‘s stock had its “neutral” rating reaffirmed by research analysts at DA Davidson in a report released on Feb. 11. They currently have a $2.70 target price on the stock, up from their previous target price of $1.75.

Is ANAD a Buy after the Solid report? Get Special Coverage Here

Mitek Systems, Inc. (NASDAQ:MITK) shares dropped 13.99% and closed at $4.18 in the last trading session. The company released its earnings data on Jan. 31. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $3.30 million for the quarter, compared to the consensus estimate of $2.19 million. During the same quarter in the previous year, the company posted $0.02 earnings per share. The company’s revenue for the quarter was down 5.7% on a year-over-year basis.

How Should Investors Trade MITK After The Latest Report? Find Out Here

Gevo, Inc. (NASDAQ:GEVO) shares declined 12.24% to $2.08. The company announced that the company will host a conference call on Tuesday, March 5, 2013 at 4:30 p.m. EST (2:30 p.m. MST) to report its financial results for the fourth quarter ended Dec. 31, 2012 and provide an update on recent corporate highlights.

How Should Investors Trade GEVO After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.